The cardiovascular (CV) benefit of glucose lowering, particularly if too intensive, in type 2 diabetes mellitus (T2DM) is currently debated. Some modalities have even been reported, unexpectedly, to be associated with worse CV outcomes. To investigate the CV profile of the novel DPP-4 inhibitor linagliptin, a pre-specified meta-analysis of all …

Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath   Mr. KM was referred to a diabetes center by his GP. Mr. KM is a 77-year-old man who has had type 2 diabetes for 17 years: current HbA1c 9.5%; random …

This week’s Homerun Slides cover eye diseases including Efferent Cranial Neuropathy, Glaucoma, AION and Retinal Vascular Occlusion….

This week I picked up my new glasses and was chatting with the optometrist about how many of his patients have diabetes. Dr. Adler sees a good number of them as his population is a little older and what surprises him is that they often make no connection between diabetes and …

Artificial Pancreas Closer to Reality See this week’s Item #1, ADA: Scientists Getting Closer to Artificial Pancreas.

With lawmakers and diabetes advocates ramping up the pressure, U.S. officials this week outlined a regulatory path for a preliminary version of the device….

Preventive treatment with metformin or lifestyle intervention in patients with type 2 diabetes reduced the cost of medical care, including costs for inpatient and outpatient care and prescriptions, compared with placebo….

Liraglutide, recently approved in the United States for the treatment of type 2 diabetes, has demonstrated its potential as a weight-loss drug for nondiabetic, obese patients….

Intensive dietary intervention and dietary intervention combined with an increase in moderate activity were both  superior to usual care in a real-world comparison of diabetic patients in the first 6 months after being diagnosed.…

Insulin pumps that automatically shut down when blood glucose hits a certain low level decrease the amount of time pediatric patients spend in hypoglycemia….